TickerFacts.

Agentix Corp. (AGTX): Cash & Equivalents

Annual figures by period end, from SEC filings.

$771
As of 2026-03-31
-60.4%
3-year compound annual growth
$242.8K2014-08-31: $134.8K2015-08-31: $13.2K2016-08-31: $6192017-08-31: $3.7K2018-08-31: $2.1K2020-08-31: $242.8K2021-08-31: $1.8K2022-03-31: $1452023-03-31: $12.4K2026-03-31: $771$771
2014-08-31 Cash & Equivalents (USD) 2026-03-31
Period endedCash & EquivalentsChange YoYSource filing
2026-03-31$771n/a2026-07-01, Balance as of period end
No annual figure between 2023-03-31 and 2026-03-31.
2023-03-31$12.4Kn/m2023-07-14, Balance as of period end
2022-03-31$145n/a2023-07-14, Balance as of period end
2021-08-31$1.8K-99.3%2021-10-07, Balance as of period end
2020-08-31$242.8Kn/a2021-10-07, Balance as of period end
No annual figure between 2018-08-31 and 2020-08-31.
2018-08-31$2.1K-42.4%2019-12-05, Balance as of period end
2017-08-31$3.7K+495.8%2018-11-13, Balance as of period end
2016-08-31$619-95.3%2017-12-18, Balance as of period end
2015-08-31$13.2K-90.2%2016-12-12, Balance as of period end
2014-08-31$134.8Kn/a2015-12-16, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Agentix Corp. (AGTX)2026-03-31$771n/a
Mosaic ImmunoEngineering Inc. (CPMV)2025-12-31$3.6K-96.9%
Adaptin Bio, Inc. (APTN)2025-12-31$459.2Kn/m
Brainstorm Cell Therapeutics Inc. (BCLI)2025-12-31$29.0K-84.5%
Abpro Holdings, Inc. (ABPO)2024-12-31$2.85M+294.2%
Estrella Immunopharma, Inc. (ESLA)2025-12-31$1.38M+51.0%
BioCardia, Inc. (BCDA)2025-12-31$2.50M+5.3%
Tevogen Inc. (TVGN)2025-12-31$0n/a
Eloxx Pharmaceuticals, Inc. (ELOX)2025-12-31$4.79Mn/m

Compare AGTX, CPMV, APTN, BCLI side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗